Superion IDE Trial

VertiFlex® conducted a clinical trial in the United States on the Superion Interspinous Spacer System. 31 prestigious U.S. spine centers were involved, with both spine surgeons and interventional spine physicians serving as the trial’s principal investigators.

Enrollment was completed with 470 patients in December, 2011. 3-Year follow up is complete and on May 20, 2015 the FDA approved the device for U.S. distribution.

© 2016 VertiFlex Inc.

Superion Interspinous Spacer

Superion® Interspinous Spacer